• 202.466.8960
  • Contact Us
Feldesman Tucker Leifer Fidell LLP Menu   ≡ ╳
  • About Us
    • Careers
    • Contact Us
  • Attorneys
  • Practice Areas
    • Federal Grants
      • Services
      • Whom We Serve
      • Training
      • Grants Resource Center
      • Blog
    • Health Law
      • Services
      • Whom We Serve
      • Training
      • Health Law Resources
      • Blog
    • Family Law
      • Services
      • Whom We Serve
      • Process Choices
      • Testimonials
      • Blog
      • Newsletter Archive
      • FAQ Videos
    • Litigation & Gov’t Investigations
      • Litigation
      • False Claims Act
      • FIRREA
      • Government Investigations
      • Internal Investigations
      • White Collar Defense
  • News
    • Blogs
      • Federal Grants
      • Health Law
      • Family Law
      • False Claims Act
    • Client Alerts
  • Training
  • Contact Us

FTLF Partner Jason B. Reddish to Speak on 340B Compliance

Posted June 18, 2019 By Jason B. Reddish

On Wednesday, June 19, FTLF Partner Jason B. Reddish will be featured in a webinar hosted by The Urban Coalition… Read More

FTLF Partner Jason B. Reddish to Speak at the 2nd Annual ATRIA 340B Forum

Posted May 13, 2019

FTLF Partner Jason B. Reddish will be in Lake Placid, New York this week to participate in the Read More

FTLF Partner Michael B. Glomb to Speak on 340B Compliance

Posted April 8, 2019 By Michael B. Glomb

FTLF Partner Michael B. Glomb, a senior member of FTLF’s Health Law Practice Group, will make a presentation on Using 340B Drugs Across the… Read More

The Dawn of New Era: the 340B Ceiling Price Database Goes Live

Posted April 8, 2019 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

Covered entities in the 340B Discount Drug Program now can verify that drug manufacturers are charging them no more than the “ceiling price”… Read More

The Trump Administration Wants to Put an End to PBM Rebates

Posted February 13, 2019 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

On January 31, 2019, the Trump Administration announced proposed changes to safe harbor protections under the Anti-Kickback Statute (AKS), which… Read More

California Gov. Newsom Signals Big Threat to 340B Providers in Plan for Statewide Single-Purchaser System for Prescription Drugs

Posted January 11, 2019 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

Judge Vacates Hospital Medicare Part B 340B Drug Payment Cuts; HHS Exceeded Authority in Drastically Reducing Reimbursement

Posted December 28, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

On December 27, hospitals participating in the federal 340B drug discount program that are paid under the Medicare Outpatient Prospective Payment… Read More

HRSA Updates Ryan White HIV/AIDS Program Policy on Care in Correctional Settings; 2018 RWHAP Update

Posted November 29, 2018 By Jason B. Reddish & Scott S. Sheffler

 

New guidance clarifies ability of RWHAP providers to partner with city, county, and local jails for HIV/AIDS care and… Read More

House Energy & Commerce Committee Seeks Answers from 340B Program Contract Pharmacies

Posted August 7, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

Read More

Recent Developments with Contract Pharmacies and Other 340B Updates

Posted July 6, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

On July 3rd, the Health Subcommittee of the House Energy & Commerce Committee announced a hearing entitled, “Read More

340B Roundup: The Senate and White House Focus on the 340B Program; Manufacturer Oversight and Overcharge Penalties Delayed (Yet Again)

Posted May 23, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

The 340B program continues to garner the attention of Congress and the Trump Administration.  In a recent flurry of activity, the Senate Health,… Read More

REMINDER TO FQHCs TO RECERTIFY!

Posted February 13, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

Each year, as required by the 340B statute, the Office of Pharmacy Affairs (OPA) requires covered entities to recertify that they meet the 340B… Read More

Senator Cassidy (R-LA) Introduces 340B Legislation That Would Impose 340B Claims Identification Requirements on All Covered Entities and a Hospital Moratorium

Posted February 2, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

On January 16, 2018, Senator Cassidy (R-LA) introduced the bill, Helping Ensure Low-income Patients have Access to Care and Treatment (HELP Act).… Read More

House Energy and Commerce Committee Issues Report on Review of 340B Program and Recommends Potentially Significant Changes

Posted January 12, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

Three hearings before the House Energy and Commerce (E&C) Committee and its Oversight and Investigation SubcommitteeRead More

Year End 340B Round-Up: Hospital Moratorium Legislation Introduced; Hospital Payment Cuts Take Effect After Suit Hits Snag but Congress May Intervene

Posted January 5, 2018 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

The closing months of 2017 saw a flurry of activity related to the 340B drug pricing program, both as a topic of legislative and regulatory… Read More

CMS Cuts Medicare Part B 340B Drug Reimbursement in Hospital Outpatient Departments by Nearly 30 Percent

Posted November 3, 2017 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

On November 1, 2017, the Centers for Medicare & Medicaid Services (CMS) finalized the Read More

Congress Seeks Information from 340B Covered Entities and Holds Hearing to Discuss How Covered Entities Use 340B Savings

Posted October 17, 2017 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

On October 11, 2017, the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee convened a hearing on the use of… Read More

Enforcement of Manufacturer Overcharge Penalty Rule Delayed Until July 1, 2018; HRSA Might Propose New Rule

Posted October 17, 2017 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

HRSA has finalized its proposal to delay enforcement of its final rule imposing civil monetary penalties (CMPs) on manufacturers that overcharge… Read More

HRSA Proposes to Delay Enforcement of Manufacturer Overcharge Penalty Rule Until July 1, 2018; Seeks Comment on Delay

Posted August 18, 2017 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

HRSA is proposing to delay enforcement of its final rule imposing civil monetary penalties on manufacturers that overcharge 340B program covered… Read More

CLIENT ALERT: 340B Database Offline August 15 to Mid-September; Plan Ahead NOW

Posted August 11, 2017 By Elizabeth J. Karan & Jason B. Reddish & Michael B. Glomb

Covered entitles and 340B program stakeholders should prepare now for a disruption to the 340B Office of Pharmacy Affairs Information System (340B… Read More

  • 1
  • 2
  • →

Practice Area Blogs

  • Federal Grants
  • Health Law
  • Family Law
  • False Claims Act

Related Posts

  • Is There Light at the End of the Divorce Tunnel?
    July 22, 2015
  • HHS OIG’s Assessment of Continuing Vulnerabilities in HHS’s Small Business Innovation Research Program
    April 4, 2019
  • When Do You Need a Child Custody Evaluation in Divorce?
    June 18, 2019
  • What You Should Expect from Your Divorce Lawyer
    May 22, 2019
View All Of
Our Blogs
Footer Menu   ≡ ╳
  • Federal Grants
  • Health Law
  • Family Law
  • Attorneys
  • About Us
  • Blog
  • Training
  • Contact Us

© 2019 Feldesman Tucker Leifer Fidell LLP.

Legal & Privacy

Attorney Advertising Notice: Prior results do not guarantee a similar outcome. If you have any questions concerning attorney advertising rules, please contact: Feldesman Tucker Leifer Fidell LLP | 1129 20th Street, NW, Suite 400 | Washington, DC 20036 T. 202. 466.8960 | F. 202. 293.8103